Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Direct effects of glucagon-like Peptide-1 receptor agonists on mitochondrial function in human-derived in vitro models: A systematic review and meta-analysis
Metabolism open, 2026;31:100484
Evidence That Semaglutide Represents an Important Tool for Treatment of Irregular Menses and Chronic Anovulation in Women with Polyendocrine Metabolic Ovarian Syndrome
Journal of clinical medicine, 2026;15(13)
Postshortage Compounded GLP-1 RA Market in 2 States With Potentially High Demand
JAMA health forum, 2026;7(7):e262207
Incretin-based cardiovascular protection beyond diabetes: evidence, mechanisms, and therapeutic frontiers from GLP-1 receptor agonists to multi-agonist therapy
Frontiers in endocrinology, 2026;17:1870649
Anti-Obesity Drugs: The Rising Significance of GLP-1Agonist, Tirzepatide
Journal of mid-life health, 2026;17(2):206-207
Corrigendum to “Impact of tirzepatide on systemic arterial stiffness assessed by cardio-ankle vascular index in individuals with obesity complicated by type 2 diabetes: A retrospective cohort study in Japan” [Obesity Pillars 19 (2026) 100291]
Obesity pillars, 2026;19:100294
Semaglutide in Schizophrenia-A Top Clinical Trial
JAMA psychiatry, 2026
Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: a bibliometric analysis of global research trends and research hotspots from 2006 to 2025
Naunyn-Schmiedeberg's archives of pharmacology, 2026
Starvation-Type Euglycemic Ketoacidosis After Unsupervised Tirzepatide Use in a Non-Obese, Non-Diabetic Woman
The American journal of case reports, 2026;27:e952750
Effects of Supplementation in Masters Athletes and Older Adults: A Narrative Review
Current sports medicine reports, 2026;25(7):216-223
Efficacy and Safety of Intensifying Once-Weekly Insulin Icodec Treatment With Once-Weekly Semaglutide in Adults With Type 2 Diabetes: A Single-Arm, Open-Label, Treat-to-Target, Phase 3b Trial (ONWARDS 8)
Diabetes, obesity & metabolism, 2026
Tirzepatide Is Associated With Improved Metabolic Outcomes in People With Type 1 Diabetes and Overweight or Obesity: A Retrospective Cohort Study
Diabetes, obesity & metabolism, 2026
Tirzepatide as a multi-organ integrator in metabolic diseases: a review of molecular mechanisms and clinical translation
Endocrine, 2026;91(1)
Effects of Retatrutide on Learning and Memory in Streptozotocin-Induced Male Diabetic Rats
Behavioural brain research, 2026;:116343
Concurrent diabetic ketoacidosis, acute pancreatitis, and subsequent ruptured acalculous cholecystitis in a patient receiving semaglutide: A case report
SAGE open medical case reports, 2026;14:2050313X261463142
Effects of GLP-1 Receptor Agonists on Psoriasis: An “Agent-Specific” Systematic Review of the Literature
Journal of clinical medicine, 2026;15(13)
Tirzepatide and reduced risk of pulmonary embolism and deep vein thrombosis: a multicenter U.S. cohort study
Frontiers in endocrinology, 2026;17:1885961
Hormonal Contraception and Initiation of Semaglutide Therapy
JAMA network open, 2026;9(7):e2624382
Body Composition Changes During GLP-1 Receptor Agonist Therapy in Pediatric Obesity: A Pilot Study
Metabolites, 2026;16(7)
Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial
Annals of internal medicine, 2026